CJC-1295 DAC
Growth hormone-releasing hormone analog incorporating a Drug Affinity Complex, studied for extended growth hormone elevation.
Amino-acid chains studied as signaling molecules, including growth hormone secretagogues, repair peptides, melanocortins, and neuropeptides.
Growth hormone-releasing hormone analog incorporating a Drug Affinity Complex, studied for extended growth hormone elevation.
Recombinant form of the follistatin glycoprotein, studied as a myostatin-binding regulator in muscle-growth research.
Synthetic growth hormone-releasing peptide and ghrelin receptor agonist, studied for stimulation of growth hormone secretion.
First-generation growth hormone-releasing peptide and ghrelin receptor agonist, studied for growth hormone release and appetite signaling.
Synthetic growth hormone secretagogue and ghrelin receptor agonist, studied for growth hormone release and cardiovascular research.
Truncated analog of insulin-like growth factor 1 missing three N-terminal residues, studied for localized growth-factor signaling.
Long-acting analog of insulin-like growth factor 1 with an extended half-life, studied for anabolic and growth-factor signaling research.
Selective growth hormone secretagogue and ghrelin receptor agonist, studied for growth hormone release with minimal effect on other hormones.
Modified growth hormone-releasing hormone analog, studied for stimulation of endogenous growth hormone secretion.
Synthetic analog of growth hormone-releasing hormone, studied for stimulation of endogenous growth hormone secretion.
Stabilized growth hormone-releasing hormone analog developed by Theratechnologies, studied for reduction of visceral adipose tissue.